Literature DB >> 10752709

Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women.

P Garnero, E Sornay-Rendu, P D Delmas.   

Abstract

The link between serum insulin-like growth factor 1 (IGF-1) and postmenopausal osteoporosis remains controversial. In this study of healthy postmenopausal women, decreased serum concentrations of IGF-1 were strongly associated with an increased risk of osteoporotic fractures independently of bone-mineral density.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10752709     DOI： 10.1016/s0140-6736(99)05463-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  57 in total

Review 1.  The role of circulating IGF-I: lessons from human and animal models.

Authors:  Shoshana Yakar; Yiping Wu; Jennifer Setser; Clifford J Rosen
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

Review 2.  The IGF-I regulatory system and its impact on skeletal and energy homeostasis.

Authors:  Masanobu Kawai; Clifford J Rosen
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

3.  Differences in exposure to stimulatory and inhibitory components of the insulin-like growth factor (IGF) system in patients with femoral neck versus trochanteric fracture.

Authors:  S Boonen; D Vanderschueren; K Venken; P Geusens; P Haentjens; S Mohan; D J Baylink; R Bouillon
Journal:  Age Ageing       Date:  2005-03       Impact factor: 10.668

4.  Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions.

Authors:  Shoshana Yakar; Ernesto Canalis; Hui Sun; Wilson Mejia; Yuki Kawashima; Philip Nasser; Hayden-William Courtland; Valerie Williams; Mary Bouxsein; Clifford Rosen; Karl J Jepsen
Journal:  J Bone Miner Res       Date:  2009-08       Impact factor: 6.741

Review 5.  Systems analysis of bone.

Authors:  Karl J Jepsen
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2009 Jul-Aug

6.  IGF-1 and survival in ESRD.

Authors:  Ting Jia; Thiane Gama Axelsson; Olof Heimbürger; Peter Bárány; Bengt Lindholm; Peter Stenvinkel; Abdul Rashid Qureshi
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

7.  Circulating levels of IGF-1 directly regulate bone growth and density.

Authors:  Shoshana Yakar; Clifford J Rosen; Wesley G Beamer; Cheryl L Ackert-Bicknell; Yiping Wu; Jun-Li Liu; Guck T Ooi; Jennifer Setser; Jan Frystyk; Yves R Boisclair; Derek LeRoith
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

8.  The role of IGF-I and IGFBP-1 status and secondary hyperparathyroidism in relation to osteoporosis in elderly Swedish women.

Authors:  H Salminen; M Sääf; H Ringertz; L E Strender
Journal:  Osteoporos Int       Date:  2007-09-14       Impact factor: 4.507

9.  The insulin-like growth factor-1 binding protein acid-labile subunit alters mesenchymal stromal cell fate.

Authors:  J Christopher Fritton; Yuki Kawashima; Wilson Mejia; Hayden-Williams Courtland; Sebastien Elis; Hui Sun; Yinjgie Wu; Clifford J Rosen; David Clemmons; Shoshana Yakar
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

10.  The insulin-like growth factor system: towards clinical applications.

Authors:  Leon A Bach
Journal:  Clin Biochem Rev       Date:  2004-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.